Interventional Pharmacology An Issue Of Interventional Cardiology Clinics

This issue of Interventional Cardiology Clinics reviews pharmacologic agents currently used to treat patients in the cath lab. All the pharmaceutical knowledge an interventionalist needs is summarized in this handy reference.

This issue of Interventional Cardiology Clinics, guest edited by Dr. Srihari S. Naidu, will discuss Interventional techniques for Heart Failure. Subjects covered in the articles include, but are not limited to: Invasive Hemodynamics of Myocardial Disease: Systolic and Diastolic Dysfunction; Invasive Hemodynamics of Pericardial Disease: Constriction and Tamponade; Invasive Hemodynamics of Pulmonary Disease and the Right Ventricle; TAVR and MitraClip to Reverse Heart Failure; Mechanical Circulatory Support in Acute Decompensated Heart Failure and Shock; Adult Congenital Interventions in Heart Failure; Future Directions in Device Treatment of Heart Failure; and Prioritizing and Combining Interventional Therapies for Heart Failure, among others.

This issue of Interventional Cardiology Clinics will explore Updates in Percutaneous Coronary Intervention. Curated by the series Editor-in-Chief, Dr. Matthew J. Price, this issue will cover topics and advances in the field that are relevant for practicing clinicians. This issue is one of four selected each year by Dr. Price. The volume will include articles on: Current Concepts in Intraprocedural Pharmacology During PCI; Periprocedural Myocardial Infarction in Contemporary Practice; Newer Generation Metallic Stents: Design, Performance Characteristics, and Outcomes; Distal Transradial Access for Coronary Angiography and Intervention; Clinical Outcomes Data for iFR-guided PCI; Culprit-only or Complete Revascularization During STEMI in Patients with and Without Shock; Technical Approaches to Left Main Coronary Intervention: Contemporary Best Practices; Robotic Assisted Percutaneous Coronary Intervention; Orbital Atherectomy: A Comprehensive Review; and Percutaneous revascularization of spontaneous coronary artery dissection, among others.

Heart disease is the leading cause of death among US women over the age of 65, resulting in more deaths than all forms of cancer combined. Women are less likely to survive heart attacks than are men, possibly because symptoms in women may differ and may be less recognizable. In addition, women consistently tend to have worse clinical outcomes in percutaneous coronary interventions than do men. For these reasons, an issue on percutaneous interventions in women is timely.

This issue of Interventional Cardiology Clinics, edited by Allen Jeremias, is devoted to Intravascular Physiology. Dr. Jeremias assembled a group of expert contributors to review the following topics: Evolution of Coronary Physiology – Basic Concepts of FFR and CFR; Concept of "Functional PCI" – The Rational for Physiologic Lesion Assessment for PCI Guidance; Limitations and Pitfalls of FFR and Adenosine-Induced Hyperemia; Evidence for the Use of FFR to Guide Clinical Decision-Making – The Landmark FFR Clinical Trials; Evaluation of Microvascular Disease and Clinical Outcomes; Hyperemic vs. Resting Indices for the Assessment of CAD; FFR for the Evaluation of Tandem and Bifurcations Lesions, Left Main, and Acute Coronary Syndromes; and CT-FFR: Basic Concept and Clinical Implementation.

This issue of Interventional Cardiology Clinics, Guest Edited by Dr. Brian O’Neill, will focus on Mechanical Circulatory Support. This issue is one of four selected each year by the series Consulting Editor, Dr. Marvin H. Eng. Mechanical circulatory support (MCS) plays an important role in the management of a variety of patients with a range of conditions in interventional cardiology. As many times the question of MCS arises in the most critical of patients, an understanding of each of the devices along with which patients may potentially benefit is vital. This issue aims to provide a review of the various options of MCS, as well as a variety of scenarios in which MCS may play a beneficial role in the management of patients.

While all interventional cardiologists have access to pharmacopeial texts and databases and are aware of the growing number of pharmacological agents in the armamentarium, questions arise as to the ideal agent or combination of agents in differing patient situations. This superb text offers the reader coverage of all the major pharmacological t

This issue of Interventional Cardiology Clinics reviews percutaneous circulatory support device use in several situations, including left and right ventricular shock, cardiopulmonary resuscitation, and infarct size reduction. Keep up to date with the latest developments in this rapidly evolving field.